Coris Bioconcept SRL
31.2 FTECoris Bioconcept reported revenue of €5.45m for the 2026 financial year (annual accounts filed with the NBB on 14 Oct 2026), with 31.2 full-time equivalents.
The score of Coris Bioconcept shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2026
Change 2023 → 2026: Revenue -9 % Equity -15 % Total assets -20 % Headcount (avg FTE) +17 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Coris Bioconcept's annual accounts
| 2026 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | €5.45m | ||||
| Net result | −391,631 € | ||||
| Equity | €5.02m | ||||
| Cash | 815,481 € | ||||
| EBITDA | 179,031 € | ||||
| Total assets | €6.11m |
Filed annual accounts
- Year ended 31 Mar 2026filed on 14 Oct 2026
- Year ended 31 Dec 2024filed on 25 Sep 2025
- Year ended 31 Dec 2023filed on 20 Aug 2024
- Year ended 31 Dec 2022filed on 29 Aug 2023
- Year ended 31 Dec 2021filed on 30 Aug 2022
Coris Bioconcept's financial analysis
- Solvency82.1%sector median: 43.9%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Coris Bioconcept
Coris Bioconcept's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0459.020.430
- VAT number
- BE0459020430
- Peppol
- Registered · 0208:0459020430 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 16 Oct 1996
- Registered office
- 5032 Gembloux
- Size
- Small · 31.2 FTE
- Latest accounts
- 2026 · filed on 14 Oct 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Coris Bioconcept (SRL) has been based in Gembloux since 1996, active in: wholesale of pharmaceutical and medical goods. For 2026, it reports revenue of €5.45m, a net loss of 391,631 € and equity of €5.02m. With 31.2 full-time equivalents, it is a small enterprise by headcount. Its solvency stands at 82.1%, above the median of its sector (43.9%).
Companies similar to Coris Bioconcept
Companies in the same business, of comparable size and area, outside its group.
- Goodlife Pharma Wholesale of pharmaceutical and medical goods Chastre · balance sheet €4.30m
- Eqwal Care Wholesale of pharmaceutical and medical goods Ghent · balance sheet €6.10m
- Remedus Wholesale of pharmaceutical and medical goods Kontich · balance sheet €4.25m
- LS Innoventa Wholesale of pharmaceutical and medical goods Genk · balance sheet €5.35m
- Dialex Biomedica Wholesale of pharmaceutical and medical goods Bilzen-Hoeselt · balance sheet €7.97m
- Aguettant SA/NV Wholesale of pharmaceutical and medical goods Brussels · balance sheet €4.15m
- Enovis Surgical Belux Wholesale of pharmaceutical and medical goods Leuven · balance sheet €9.19m
- Prodivet Pharmaceuticals Wholesale of pharmaceutical and medical goods Raeren · balance sheet €3.32m
Frequently asked questions about Coris Bioconcept
What is the revenue of Coris Bioconcept?
According to the 2026 annual accounts filed with the NBB, the revenue of Coris Bioconcept amounts to 5,452,741 €.
What is the VAT number of Coris Bioconcept?
In Belgium, the VAT number is the company number prefixed with BE: BE0459020430 for Coris Bioconcept, if the company is VAT-registered. Its company number (CBE) is 0459.020.430.
Where is the registered office of Coris Bioconcept?
According to the CBE register, the registered office of Coris Bioconcept is in 5032 Gembloux.
What is the equity of Coris Bioconcept?
At the close of the 2026 financial year, the equity of Coris Bioconcept amounts to 5,018,570 €, a solvency of 82.1% of total assets.
How many people work at Coris Bioconcept?
31.2 full-time equivalents on average according to the 2026 social balance sheet.
Who manages Coris Bioconcept?
The register lists 4 active mandates at Coris Bioconcept. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Coris Bioconcept
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →